FDA Greenlights Bayer's Kovaltry Therapy For Hemophilia A

Bayer's hemophilia A Kovaltry therapy received approval from the FDA. Kovaltry therapy is designed to help control bleeding and reduce the number of episodes through repetitive prophylaxis.